Coronaviruses (CoV) are positive-sense RNA viruses that infect numerous mammalian and avian 23 species and are capable of causing severe and lethal disease in humans. CoVs encode several 24 innate immune antagonists that interact with the host innate immune response to facilitate 25 efficient viral replication. CoV non-structural protein 14 (nsp14) encodes 3'-to-5' 26 exoribonuclease activity (ExoN), which performs a proofreading function and is required for 27 high-fidelity replication. Outside of the order Nidovirales, arenaviruses are the only RNA viruses 28 that encode an ExoN, which functions to degrade dsRNA replication intermediates. In this study, 29
INTRODUCTION 67
The innate immune response within a mammalian cell is the first line of defense against 68 an invading pathogen. However, as obligate intracellular parasites, viruses have evolved 69 numerous mechanisms to prevent and antagonize innate detection by host cells. Coronaviruses 70 (CoVs), which are the largest known positive-sense, single-stranded RNA viruses, encode 71 several type I interferon (IFN) antagonists. Many of these antagonists prevent the induction of 72 IFN, while others mediate resistance to the effects of IFN (1-3). Upon secretion from a cell, IFNs 73 bind to cell surface-expressed IFN-α/β receptors (IFNARs) in an autocrine and paracrine manner. 74
Subsequently, an IFN signaling cascade utilizing the Janus kinase and signal transducer and 75 activator of transcription pathway leads to the induction and expression of hundreds of interferon 76 stimulated genes (ISGs) that act to limit or prevent viral replication and spread (4). However, 77 during CoV infection, nonstructural protein (nsp) 1 antagonizes the innate immune response by 78 degrading host mRNAs and suppressing IFN beta (IFN-β) expression (5, 6). The nsp3 of severe 79 acute respiratory syndrome coronavirus (SARS-CoV) prevents IRF3 phosphorylation and NF-κB 80 signaling (7). In addition, SARS-CoV nsp3 encodes deubiquitinating and deISGylating activities 81 (3, 8) . CoV viral RNA evades innate detection by pattern recognition receptors (PRRs) such as 82 MDA5, and antiviral effectors, such as IFIT1, through formation of a 5' cap-1 structure by 83 encoding N7-methyltransferase and 2'O-methyltransferase activities within nsp14 and nsp16, 84 respectively (9, 10). Murine hepatitis virus (MHV) and Middle East respiratory syndrome 85 coronavirus (MERS-CoV) also encode 2'-5' phosphodiesterases that degrade 2'-5' 86 oligoadenylates, which are key signaling molecules generated by oligoadenylate synthetase 87 (OAS) in response to innate detection of dsRNA that subsequently activate RNase L (11). Most 88 recently, a CoV nsp15 endonuclease activity (EndoU) mutant virus was shown to have increased 89 dsRNA levels, suggesting that nsp15 EndoU reduces dsRNA levels during infection (12) . 90 CoV nsp14 encodes 3'-to-5' exoribonuclease (ExoN) and N7-methyltransferase (N7-91 MTase) activities (9, 13). CoV nsp14 N7-MTase activity is essential for efficient translation of 92 the viral genome and preventing innate detection (14) . In addition, initial biochemical studies of 93 nsp14 ExoN activity demonstrated that ExoN has a preference for dsRNA and the capacity to 94 excise 3' end misincorporated nucleotides (13). Moreover, nsp14 ExoN activity is required for 95 high-fidelity replication. The CoV nsp14 ExoN is a member of the DE-D-Dh superfamily of 96 DNA and RNA exonucleases, so named for the three motifs of four active site residues (13). 97
Betacoronaviruses SARS-CoV and MHV expressing engineered, ExoN-inactivating 98 substitutions at active site residues in Motif I (DE!AA) [ExoN(-)] demonstrate increased 99 mutation frequencies and are profoundly sensitive to inhibition by RNA mutagens (15, 16) . 100
Additionally, SARS-CoV ExoN(-) virus is attenuated in vivo (17). Interestingly, outside of the 101 order Nidovirales, the only other known RNA virus-encoded 3'-to-5' exoribonucleases are found 102 in the Arenaviridae family of viruses. Lassa fever virus nucleoprotein ExoN is not thought to 103 participate in fidelity regulation, but rather it participates in immune evasion by degrading 104 dsRNA and thereby prevents antigen-presenting cell-mediated NK cell activation (18) (19) (20) . 105
Recently, in the Alphacoronavirus transmissible gastroenteritis virus (TGEV), a mutation in the 106 nsp14 ExoN zinc finger was shown to generate lower levels of dsRNA compared to wild-type 107 (WT) TGEV. However, in that study viruses with mutations in ExoN active site motifs were 108 non-viable and therefore, could not be directly tested for effects on innate immunity (21). 109
Here, we demonstrate that viruses lacking ExoN activity were sensitive to the effects of 110 IFN pretreatment. In addition, for viruses lacking ExoN activity, replication was restricted in 111 wild-type bone marrow derived macrophages (B6, BMMs) but restored in interferon alpha/beta 112 receptor deficient (IFNAR-/-) BMMs. Despite an increased sensitivity to the effects of IFN 113 treatment, MHV ExoN mutants failed to induce detectable IFN-β gene expression or RNase L-114 mediated ribosomal RNA (rRNA) degradation and only a limited decrease in viral RNA 115 accumulation was observed. Finally, ExoN(-) virus replicated in the presence of an IFN-β-116 mediated antiviral state had both a decreased specific infectivity and decreased relative fitness 117 compared to untreated ExoN(-) virus. Thus, nsp14 ExoN appears to block or correct the 118 restriction of MHV infection by an IFN-mediated mechanism that may involve damaging 119 nascent viral RNA and affecting subsequent infectivity. 120
121

RESULTS
122
Viruses lacking ExoN activity are sensitive to the effects of IFN-β. Binding of type I 123 interferon to the IFNAR receptor on the cell surface leads to a Jak/STAT signaling cascade that 124 ultimately results in the up-regulation and expression of hundreds of antiviral ISGs (4). In 125 addition, WT-MHV replication has been shown to be relatively resistant to the effects of IFN (1, 126 3, 22) . To determine whether the ExoN activity of MHV nsp14 was required for resistance to 127 IFN, we pretreated murine delayed brain tumor (DBT) cells with increasing concentrations of 128 mouse IFN-β for 18 h prior to infecting with WT-MHV or ExoN(-) virus at a multiplicity of 129 infection (MOI) of 1 plaque-forming unit (PFU) per cell ( Fig. 1A) . In response to IFN-β 130 pretreatment, WT-MHV viral titer decreased by approximately 1 log 10 as previously reported (1) . 131
In contrast, ExoN(-) viral titer demonstrated a dose-dependent decrease and resulted in an 132 approximately 3 log 10 decrease in viral titer relative to untreated ExoN(-) viral titers. The ExoN 133 activity of nsp14 is conferred by active site residues present in 3 different motifs within the 134 ExoN domain (23). Therefore, to determine whether the observed sensitivity to IFN-β 135 pretreatment for ExoN(-) virus in Fig. 1A was due specifically to the absence of ExoN activity in 136 nsp14, we engineered and recovered a virus encoding only an aspartic acid to alanine 137 substitution in Motif III [ExoN3(-)]. Previously, we have demonstrated that viruses lacking 138 ExoN activity have decreased replication fidelity and are sensitive to the RNA mutagen 5-139 fluorouracil (5-FU) (16). Hence, 5-FU sensitivity is an in vitro indicator of ExoN activity. 140
Therefore, first, we tested whether ExoN3(-) and ExoN(-) demonstrated similar sensitivity to 5-141 FU to ensure that the ExoN activity of ExoN3(-) virus had been ablated. Similar to ExoN(-), 142 2 h delay in exponential replication and a 1 log 10 decrease in peak titer relative to WT-MHV 152 (15). Therefore, we tested whether the IFN sensitivity phenotype observed for ExoN(-) and 153 ExoN3(-) viruses is due to the decreased replication capacity of these viruses. To do so, we 154 utilized an ExoN(-) virus developed by our lab that has been blindly passaged in DBT cells for 155 250 passages [ExoN(-) P250] (24). The replication capacity of the resulting ExoN(-) P250 virus 156 exceeds that of WT-MHV ( Fig. 2A ). However, despite increased replication capacity, ExoN(-) 157 P250 demonstrated similar sensitivity to IFN-β pretreatment as ExoN(-) virus ( Fig. 2A and B) . 158
Hence, the IFN-β sensitivity phenotype of viruses lacking ExoN activity is not dependent on 159 viral replication capacity but instead, is directly associated with a specific function of nsp14 160
ExoN that is required for efficient replication in the presence of an IFN-β-mediated antiviral 161 state. 162 163 Nsp14 ExoN activity is required for replication in wild-type B6 BMMs. We next wanted to 164 test whether ExoN activity was required for IFN resistance in primary innate immune cells, such 165 as BMMs. Replication of WT-MHV in primary BMMs is well described, and data suggest that 166 wild-type B6 BMMs (B6) express many PRRs and ISGs at a higher basal level than many mouse 167 cell lines (3, 25, 26) . In contrast, BMMs lacking the IFNAR receptor (IFNAR-/-) have lower 168 basal and expressed levels of ISGs; thus, making B6 and IFNAR-/-BMMs excellent cell types 169 for interrogating the role of ExoN activity on viral replication and antagonism of the innate 170 immune response (25). BMMs from B6 or IFNAR-/-mice were generated and infected with 171 WT-MHV or ExoN(-) virus at an MOI of 1 PFU/cell. Samples were harvested at the indicated 172 time points, and viral titers were determined by plaque assay ( Moreover, an insufficient innate immune response has been proposed to be a major contributor 305 to SARS-CoV pathogenesis (29). In this study, we sought to determine the contributions of 306 nsp14 ExoN activity in the induction of and resistance to the innate immune response. We 307 demonstrate that ExoN(-) virus is sensitive to pretreatment with IFN-β. Because ExoN3(-) and 308 ExoN(-) P250 viruses were also sensitive to the effects of IFN, we conclude that IFN sensitivity 309 is specifically due to loss of ExoN activity. Fig. 4A and B) , and rRNA was intact at all 316 time-points tested (Fig. 4B) . Therefore, at least two possible explanations exist: 1.) ExoN does 317 not function to degrade dsRNA or 2.) ExoN does degrade dsRNA, but the detection of this 318 PAMP is unchanged during ExoN(-) virus infection due to sufficient antagonism by other CoV 319 proteins. Basal OAS expression levels correlate with RNase L activation (30). Thus, we 320 pretreated DBTs with IFN-β to up-regulate OAS and RNase L expression. However, rRNA 321 degradation was only observed in cells transfected with poly I:C (Fig. 4B ). Further, nsp15 322
EndoU and NS2 phosphodiesterase activities were intact during all of our experiments. Thus, it 323 is possible that in the absence of nsp14 ExoN activity, other CoV innate antagonists were 324 sufficient to prevent innate detection by the cell or prevent the induction of a detectable signal in 325 the experiments we performed. However, one would expect the endonucleolytic products of 326 nsp15 to be smaller dsRNAs that could still activate RIG-I or MDA5, similar to RNase L 327 products, unless another RNA degradation mechanism were in place (4, 31). In addition, despite 328 an intact NS2 phosphodiesterase, nsp15 mutants still activate RNase L-mediated rRNA 329 degradation (12). Lastly, when RNaseL -/-/ PKR -/-BMMs were infected with ExoN(-) virus, 330 viral replication was not rescued, suggesting that RNase L and PKR are not required for ExoN(-) 331 virus restriction (Fig. 4C) . Moreover, these data suggest dsRNA is not detected and the antiviral 332 Alpha-and Beta-CoVs is apparent but clearly differing requirements exist that may be dependent 343 on the CoV genus and cell types used. 344
Our results clearly demonstrate that viruses lacking ExoN activity are sensitive to IFN-β 345 pretreatment in a dose-dependent manner (Fig. 1A,C and Fig. 2) . Further, replication of viruses 346 lacking ExoN activity was dependent on the capacity of BMMs to express genes downstream of 347 IFNAR signaling (Fig. 3) . This is due to the fact that B6 and IFNAR-/-cells have different levels 348 of basal ISG expression and thus, two very different intracellular environments for viral 349 replication to occur (3, 25, 26). In IFNAR-/-BMMs, ExoN(-) and ExoN(-) P250 virus replication 350 capacity was restored to levels approaching or exceeding WT-MHV levels (Fig. 3) . Further, our 351 specific infectivity ( Fig. 6A ) and co-infection ( Fig. 6B) Since CoVs encode the largest genome known for RNA viruses, they have the luxury of 375 encoding multiple IFN antagonists that limit the capacity of a cell to detect and respond to 376 infection. Collectively, our data suggest that MHV nsp14 ExoN activity is a contributor to CoV 377 innate immune antagonism. We clearly demonstrate that viruses lacking ExoN activity are 378 sensitive to the effects of an IFN-β-mediated antiviral state. Further, our data reveal a critical role 379 for nsp14 ExoN activity in CoV replication and provide additional rationale for targeting nsp14 380
ExoN activity as a means of viral attenuation. Our future studies will probe the specific 381 mechanism of restriction for viruses lacking ExoN activity and assess how the requirement of 382 ExoN activity for resistance to innate immunity can be utilized for treatment during human 383 coronavirus infections. (GenBank accession number AY910861) has been previously described (37). ExoN(-) (nsp14 394 D89A and E91A) has been previously described (15). To generate ExoN(-) P250 virus, sub-395 confluent monolayers of DBT cells in 25cm 2 flasks were infected using the ExoN(-) parental 396 stock and blindly passaged for a total of 250 passages (24). For ExoN3(-) virus (nsp14 D272A), 397 site-directed mutagenesis was used to engineer point mutations in the MHV genome cDNA F 398 fragment plasmid using the MHV infectious clone reverse genetics system (37). ExoN3(-) 399 mutant virus was recovered using BHK-R cells following electroporation of in vitro-transcribed 400 genomic RNA. Recovered ExoN3(-) virus was sequenced (GenHunter Corporation, Nashville, 401 TN) to verify the engineered mutations were present and to ensure that no additional mutations 402 were introduced. 403 404 Interferon-β sensitivity assays. Sub-confluent DBT cells were treated for 18 h with the 405 indicated concentrations of mouse IFN-β (PBL Assay Science) prior to infection with virus at a 406 multiplicity of infection (MOI) of 1 plaque-forming unit (PFU) per cell at 37°C for 45 min. After 407 incubation, inocula were removed, cells were washed with PBS, and fresh medium was added. 408
Cell culture supernatants were collected at 12 h post-infection, and viral titers were determined 409 by plaque assay (15). 410 411 5-FU sensitivity assays. Sub-confluent DBT cells were treated with DMEM supplemented to 412 contain the indicated concentrations of 5-fluorouracil [(5-FU), Sigma] or DMSO alone at 37°C 413 for 30 min. After incubation, drug was removed and cells were infected with virus at an MOI of 414 1 PFU/cell at 37°C for 1 h. Inocula were removed, and cells were incubated in medium 415 containing 5-FU or DMSO. Cell culture supernatants were collected at 12 h post-infection, and 416 viral titers were determined by plaque assay. 417 418 Virus replication kinetics. Bone-marrow derived macrophages (BMMs) were generated from 419 the hind limbs of WT, IFNAR-/-, or RNaseL-/-/PKR-/-C57/B6 mice as previously described 420 (11). BMMs were infected with virus at an MOI of 1 PFU/cell at 37°C for 1 h. After incubation, 421 inocula were removed, cells were washed with 3 times with PBS, and fresh medium was added. has been previously described (14) . Briefly, an RNA standard was prepared using the MHV A 451 fragment (37) and a standard curve was generated using 10-fold dilutions from 10 3 to 10 8 copies. 
